UNSPSC 51343306: Opaviraline

This classification denotes a reverse transcriptase inhibitor with the molecular formula C14H17FN2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Q3A8EU2NMU, chemically known as 1(2h)-quinoxalinecarboxylic acid, 2-ethyl-7-fluoro-3,4-dihydro-3-oxo-, 1-methylethyl ester, (2s)- but generally known as opaviraline, which bears US NIH Compound Identifier 154048. The term OPAVIRALINE is an International Non-Proprietary Name. Most nations schedule opaviraline under HS 29339990 and SITC 51577.

As of Q4 2014, OPAVIRALINE remains the US FDA Preferred Term for this commodity. Opaviraline bears US NLM identifiers UMLS ID C0910816 and NCI Concept Code C90786. SMILES: CCC1C(=O)NC2=C(N1C(=O)OC(C)C)C=C(C=C2)F.

UNSPSC 51343306 Opaviraline is a Commodity code under which state and local governments procure pharmaceutical products, specifically antibiotic medications and overdose-reversal agents. Recent opportunities show state health departments and county government purchasing departments acquiring prescription medications and public-health supplies through both piggyback cooperative purchasing agreements and direct competitive bidding. The work spans warehouse fulfillment of bulk pharmaceutical orders and quarterly delivery of community health supplies to municipal health facilities. Issuing bodies include state departments of public health and county health or community services departments.

Activity appears concentrated in the South and Midwest. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical warehouse contract to Chartwell Rx LLC on August 28, 2026 (Solicitation 26482DPHPREPDB53392) for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets through the MMCAP Infuse consortium, with an initial 12-month term and two renewal options. Seminole County, Florida issued an IFB (Solicitation IFB60459723LAS, posted June 30, 2026, response due July 26, 2023) to procure 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida; the contract carried a two-year initial term with a one-year renewal option and potential FEMA funding.